4
Changes in Ownership
NORTHWEST BIOTHERAPEUTICS INC Filed Acc 0001144204-17-032807
Options or other derivatives
- Chief Scientific Officer acquired 3,402,935 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BOYNTON ALTON L Chief Scientific Officer | 2017-06-13 | Grant or award · Employee Stock Option (Right to Buy) | +3,402,935 | 3,402,935 | D | ||
Loading xslF345X03/v469119_4.xml…